МІЖНАРОДНА ДІЯЛЬНІСТЬ

Міжнародне стажування

Проф. Катерина Півторак

Online studing as latest form of modern educational on the examole of google meet and google classroom platforms. Research and Development Institute Lublin, Republic of Poland. 15.03-22.03.2021

Міжнародне вузькопрофільне науково-педагогічне стажування для викладачів закладів вищої освіти медичного профілю на базі Медичного Університету в Любліні, Польща. Online postgraduate internship for research & teaching staff from Ukraine. Медичний Університет в Любліні, Польща. 4.10 по 29.10 2021 

 

 

 

Доц. Інна Дорошкевич

International Historical Biographical Institute (Dubai – New York – Rome – Jerusalem – Beijing), international sertificate No. 1355 (International Educational Grant No. IEG/U/26/01/12), “Outstanding Personalities: Studying Experience and Proffesional Achievements for Forming a Successful Personality and Transforming of the World, Desember 10, 2025 - February 10, 2026, 6 ECTS credits (180 hours) 

 

Доц. Раїса Барало

Естонія (м. Талін) Certificate №205/2023 “Peculliarities of teaching medical disciplines in Estonia” Organized by scientific and technical organization Teadmus OU (180 hours = 6 credits ECTS), 15.10.2022 – 15.2.2023 р. (4 міс.). Онлайн.

 

Вірджинійський державний університет (VCU School of Medicine), м. Річмонд, штат  Вірджинія, США з «12» грудня 2025 р. до «04» січня 2026 р. Участь в навчальних сесіях з викладачами та феловами програми підготовки спеціалістів з гематології та онкології, зосередженої на ревматологічних аспектах у гематологічних та онкологічних пацієнтів – тактика ведення важкого пацієнта із анеміями, лекція по лікуванню залізодефіцитної анемії.    

Участь у міжнародних конгресах, форумах

Доц. Інна Дорошкевич

• Doroshkevych I.O., Kyrychenko O., Klekot A., VozniukL., Zhamba A. Association between type 2 diabetes mellitus severity and acetylating phenotype. - Мат. наукової конференції “4^th CVOT Summit in cooperation with D@CVD EASD Study group: Diabetes metabolism and the heart”. – Munich, Germany, 25.10-26.10.2018. – p. 21.
• Учасник міжнародного саміту «The Virtual CVOT Summit 2023» - Munich, Germany, 30.11-01.12.2023.
• Учасник міжнародного саміту «The Virtual CVOT Summit 2024» - Munich, Germany, 05.12-06.12.2024.

• Inna Doroshkevych, Alla Zhamba, Sviatoslav Semenenko. Is there a link between GLP-1 receptor agonists and the risk of pancreatitis? Virtual CVOT Summit 2025, 20 – 21 November 2025. European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 9.0 European CME credits (ECMEC®s). 

• Inna Doroshkevych, Alla Zhamba, Sviatoslav Semenenko. Is there a link between GLP-1 receptor agonists and the risk of pancreatitis? Virtual CVOT Summit 2025, 20 – 21 November 2025. European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 9.0 European CME credits (ECMEC®s).

 

 

Проф. Катерина Півторак

• Pivtorak Katerina, Yakovleva Olga, Fedzhaga Iryna. Endothelial dysfunction in non-alcogolic fatty liver disease. II International Scientific and Practical Conference «Education and science of today: international issues and development of sciences». Cambridge UK, 29 Oktober 2021,P80-83
• Pivtorak Kateryna, Fedzhaga Iryna, Pivtorak Natalya. Pancreatic steatosis and atherosclerotic process. Virtual 7 CVOT Summit, Munich, Germany, 18-19 November 2021 P 15-16
• Pivtorak Kateryna, Gopinath Vishnu. Potential drug-drug interactions in covid-19 patients, Fundamental and applied research in the modern world, Boston, USA, 12-14 May 2021, P.105-109.
• Pivtorak Kateryna, Yakovleva Olga, Fedzhaga Irina, Pivtorak Natalia, Zhamba Alla. Bone component of body weight in patients with non-alcoholic fatty liver disease // Abstracts of I International Scientific and Practical Conference, Boston, USA September 21 - 24, 2021.
• Pivtorak Kateryna, Yakovleva Olga, Fedzhaga Iryna, Pivtorak Natalya, Klekot Oleksandra. Sarcopenic obesity in non-alcoholic fatty liver disease //Theory and practice of modern science. III International Scientific and Theoretical Conference (Volume 2), Krakow, Republic of Poland: European Scientific Platform. April 1, 2022,  85-87.
• Pivtorak Kateryna, Yakovleva Olga, Fedzhaga Iryna. Endothelial dysfunction in non-alcoholic fatty liver disease. II International Scientific and Practical Conference «Education and science of today: intersectoral issues and development of sciences». Cambridge, UK, 29 October 2021. P 80-83.
• Pivtorak Kateryna, Yakovleva Olga, Kobirnichenko Anatolyi, Krikus Oksana. Treatment of patients with NAFLD in patients with concomitant cardiac pathology. Virtual 7 CVOT Summit, Munich, Germany, 18-19 November 2021. P 15
• Pivtorak Kateryna. Cardiovascular pathology in patients with non-alcoholic fatty liver disease with overweight and obesity. Virtual 7 CVOT Summit, Munich, Germany, 18-19 November 2021, P 10-11
• Pivtorak Kateryna. Insulin resistance, sarcopenic obesity in patients with non-alcoholic fatty liver disease. Virtual 8 CVOT Summit, Munich, Germany, 10-11 Novebmer, 2022, P 18-19
• Pivtorak Kateryna. Treatment of patients with NAFLD in patients with contamitant cardiac pathology. Virtual 7 CVOT Summit, Munich, Germany, 18-19 Novebmer, 2021, P 15
• Pivtorak V., Monastyrskiy V., PivtorakК., Prevention of nephrolithias recurrence in patients after nephrectomy. III International Scientific and Practical Conference «Débats scientifiques et orientations prospectives du développement scientifique», Paris, France, July 8, 2022. P316-317
• Pivtorak К. Non-alcoholic fatty liver disease and sarcopenic obesity. The pivotal meeting on fatty liver disease. (Dublin, Ireland, 15-17 sept. 2022). Abstract book NAFLD summit 2022:123.
• Pivtorak К. The cardiovascular assessment risk in patients with NAFLD // Abstract book Heart & Stroke Conference (25-26 January 2019, Berlin, Germany) – P. 7
• Pivtorak К. The relationship of systemic inflammation and endothelial dysfunction with blood lipid spectrum and adipokines levels in patients with NAFLD // Abstract book NAFLD Summit 2019 (26-28 September, Sevilla, Spain). – 2019. – P. 42-43.
• Pivtorak К. The role of insulin resistance, endothelial dysfunction, and systemic inflammation in the development of vascular complications in patients with NAFLD // Abstract book 5th Cardiovascular Outcome Trial Summit (24–25 October 2019, Munich, Germany). – 2019. – P. 17-18
• Pivtorak К. The state of lipid, carbohydrate metabolism and function of cardiovascular system of patients with non-alcoholic fatty liver disease, overweight and obesity // Abstract book 5th Cardiovascular Outcome Trial Summit (24–25 October 2019, Munich, Germany). – 2019. – P. 16-17
• Pivtorak К., Fedzhaga I., PivtorakN. Relationship between endothelial dysfunction and non-alcoholic fatty liver disease. The pivotal meeting on fatty liver disease. (Dublin, Ireland, 15-17 sept. 2022). Abstract book NAFLD summit. 2022:108.
• Pivtorak К., YakovlevaO., FedzhagaI., Pivtorak N., Klekot O. Sarcopenic obesity in non-alcoholic fatty liver disease. III International scientific and theoretical conference «Theory and practice of modern science» Krakow, Republic of Poland 1 April 2022. P 85-87
• Pivtorak К.V., FedzhagaI.V., Marchuk O., Pivtorak N.A. The role of atherogenic dyslipidemia, endothelial dysfunction and systemic inflammation in the development of vascular complications in patients with NAFLD. Atherosclerosis, 2023. 379: 195-196
• Pivtorak К.V., FedzhagaI.V., Pivtorak N.A. NAFLD, pancreatic steatosis and  sclerotic process. Atherosclerosis, 2022. 335: 199-200
• Pivtorak K, Ivanchuk O, Pivtorak N. Insulin resistance and sarcopenia as comorbid conditions in patients with MASLD. Jornal of Hepatology, S 499 2024.
• Pivtorak K, Ivanchuk O. The role of atherogenic dyslipidemia and disorders of thyroid gland function in the development of vascular complications in patients with MASLD. Atherosclerosis, 2024. 395: 202-203
• Pivtorak K, Ivanchuk O, Pivtorak N. Shevchuk N. Endothelial Dysfunction and Cardiovascular Pathology in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease. Diabetes, Metabolism and Heart). – 2024. – P. 13-14
• Pivtorak K., Ivanchuk O. Insulin resistance, pancreatic steatosis snd atherosclerosis.  Diabetes, Metabolism and Heart). – 2024. – P. 21-22
• Kateryna Pivtorak, Oleksandr Ivanchuk, Tatiana Shevchuk, Natalia Pivtorak, Iryna Fedzhaga, Natalia Shevchuk. Clinical association of diabetes mellitus and heart failure with metabolic dysfunction–associated steatotic liver disease. Virtual CVOT Summit 2025, 20 – 21 November 2025. European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 9.0 European CME credits (ECMEC®s). 

       

Усна доповідь на міжнародному гепатологічному конгресі 2025 у місті Амстердам

Усна доповідь онлайн на самміті у Мюнхені 2025

Доповіді на самміті зі стеатотичної хвороби печінки 2025 у м.Ештуріл (Португалія)

•  

Доц. Коновалова Н.В.

VIII International Scientific and Practical Conference «Scientific Bases Of Modern Investugations». Helsinki, Finland, 1.03-4.03.2022.

 

 

 

 

Доц. Раїса Барало

Барало Р.П., Харченко В.В., Турупалов Р.Ю. Трастузумаб в схемах хіміотерапії пацієнтів з раком молочної залози //Scientific research: modern challenges and future prospects. Proceedings of the 4th International scientific and practical conference. MDPC Publishing. Munich, Germany. 2024. Pp. 47-50.

 

 

 

 

Доц. Алла Жамба

Yakovleva O., Nikolova O., Klekot A., Vozniuk L., Zhamba A.. Association of respiratory pathology and genetic polymorphism of the Vitamin D receptor.  – Матеріали III міжнародної наукової конференції «3rd International Conference Vitamin D – Minimum, Maximum, Optimum» - м. Варшава, 2018. – С. 57.

 

Doroshkevych I.O., Kyrychenko O., Klekot A., Vozniuk L., Zhamba A. Association between type 2 diabetes mellitus severity and acetylating phenotype. - Мат. наукової конференції “4^th CVOT Summit in cooperation with D@CVD EASD Study group: Diabetes metabolism and the heart”. – Munich, Germany, 25.10-26.10.2018. – p. 21.

 

Pivtorak K., Yakovleva O., Fedzhaga I., Pivtorak N, Zhamba A. Bone component of body weight in patients with non-alcoholic fatty liver disease”. – International scientific and practical conference "Problems of modern science and practice". – Boston, USA , September – 21 - 24, 2021. – P.172-174.

Учасник міжнародного саміту «The Virtual CVOT Summit 2023» - Munich, Germany, 30.11-01.12.2023.

Учасник міжнародного саміту «The Virtual CVOT Summit 2024» - Munich, Germany, 05.12-06.12.2024.

• Inna Doroshkevych, Alla Zhamba, Sviatoslav Semenenko. Is there a link between GLP-1 receptor agonists and the risk of pancreatitis? Virtual CVOT Summit 2025, 20 – 21 November 2025. European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 9.0 European CME credits (ECMEC®s). 

• Inna Doroshkevych, Alla Zhamba, Sviatoslav Semenenko. Is there a link between GLP-1 receptor agonists and the risk of pancreatitis? Virtual CVOT Summit 2025, 20 – 21 November 2025. European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 9.0 European CME credits (ECMEC®s).

 

Ас. Оксана Крикус

Pivtorak Kateryna, Yakovleva Olga, Kobirnichenko Anatolyi, Krikus Oksana. Treatment of patients with NAFLD in patients with concomitant cardiac pathology. Virtual 7 CVOT Summit, Munich, Germany, 18-19 November 2021. P 15